Article
15 Oct 2020
Unpacking The Science And Legal Considerations Of COVID-19 Testing
AUTHORS CONTENT
Article
08 Jun 2020
Meet MoFo's Patent Counseling & Prosecution Lawyers: James Mullen
Article
30 Jan 2019
Federal Circuit Corrects USPTO On Reasonable Efforts When Calculating Patent Term Adjustment
Article
03 Jul 2017
Cancer Moonshot: USPTO Extends Cancer Immunotherapy Pilot Program Initiative
Article
08 Jul 2016
Patent Eligibility In The Life Sciences: Supreme Court Declines Review Of Ariosa Diagnostics v. Sequenom
Article
20 May 2016
USPTO Issues New Subject Matter Eligibility Examples For Life Sciences
Article
01 Jul 2013
No More Isolated DNA Patents, The Supreme Court Rules
Article
22 Apr 2013
After "Myriad" Oral Argument, Supreme Court Set To Decide Patentability Of Isolated Human DNA Molecules
Article
04 Mar 2013
Australian Federal Court Upholds Myriad’s Gene Patent
Article
11 Dec 2012
Myriad Finally Gets Its Day In (The Supreme) Court
Article
20 Aug 2012
Judges Don’t Budge In Myriad: Federal Circuit Again Finds Isolated Gene Sequences Are Patent-Eligible Subject Matter
Article
30 Jul 2012
USPTO Releases Proposed First-Inventor-To-File Rules And Examiner Guidelines
Article
03 Apr 2012
Uncertainty Prevails: Myriad Back To The Federal Circuit
Article
23 Mar 2012
"Mayo v. Prometheus": The Supreme Court Finds Certain Medical Diagnostic Claims Are Not Patent-Eligible
Article
09 Dec 2011
The Threshold Patentability Question: The Supreme Court Entertains Oral Arguments In Mayo v. Prometheus
Article
26 Sep 2011
Patent Reform Effective Dates Cheat Sheet
Article
20 Sep 2011
Patent Reform Is Upon Us
Article
13 Sep 2011
Federal Circuit Creates "Palpable" Confusion Surrounding Patent Eligibility
Article
11 Aug 2011
Federal Circuit Decision In Myriad Genetics Confirms That Isolated Human DNA Molecules Are Patentable
Article
05 Jul 2011
Patent Reform Escapes The House, Back To The Senate